[Contribution of second-generation azoles in Candida spp. infections].
Lizasoain
M
M
Unidad de Enfermedades Infecciosas, Hospital 12 de Octubre, Madrid, Spain.
Díaz Pedroche
C
C
Lumbreras
C
C
D000935:Antifungal Agents / Q000627:therapeutic use*; D001393:Azoles / Q000627:therapeutic use*; D002177:Candidiasis / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008826:Microbial Sensitivity Tests
D000935:Antifungal Agents; D001393:Azoles